首页> 外文期刊>AIDS Research and Human Retroviruses >Immunization with Clinical HIV-1 Env Proteins Induces Broad Antibody Dependent Cellular Cytotoxicity–Mediating Antibodies in a Rabbit Vaccination Model
【24h】

Immunization with Clinical HIV-1 Env Proteins Induces Broad Antibody Dependent Cellular Cytotoxicity–Mediating Antibodies in a Rabbit Vaccination Model

机译:用临床HIV-1 ENV蛋白免疫诱导兔疫苗接种模型中的宽抗体依赖性细胞细胞毒性介质介质

获取原文
获取原文并翻译 | 示例
           

摘要

The induction of both neutralizing antibodies and non-neutralizing antibodies with effector functions, for example, antibody-dependent cellular cytotoxicity (ADCC), is desired in the search for effective vaccines against HIV-1. In the pursuit of novel immunogens capable of inducing an efficient antibody response, rabbits were immunized with selected antigens using different prime–boost strategies. We immunized 35 different groups of rabbits with Env antigens from clinical HIV-1 subtypes A and B, including immunization with DNA alone, protein alone, and DNA prime with protein boost. The rabbit sera were screened for ADCC activity using a GranToxiLux-based assay with human peripheral blood mononuclear cells as effector cells and CEM.NKR_(CCR5) cells coated with HIV-1 envelope as target cells. The groups with the highest ADCC activity were further characterized for cross-reactivity between HIV-1 subtypes. The immunogen inducing the most potent and broadest ADCC response was a trimeric gp140. The ADCC activity was highest against the HIV-1 subtype corresponding to the immunogen. The ADCC activity did not necessarily reflect neutralizing activity in the pseudovirus-TZMbl assay, but there was an overall correlation between the two antiviral activities. We present a rabbit vaccination model and an assay suitable for screening HIV-1 vaccine candidates for the induction of ADCC-mediating antibodies in addition to neutralizing antibodies. The antigens and/or immunization strategies capable of inducing antibodies with ADCC activity did not necessarily induce neutralizing activity and vice versa. Nevertheless, we identified vaccine candidates that were able to concurrently induce both types of responses and that had ADCC activity that was cross-reactive between different subtypes. When searching for an effective vaccine candidate, it is important to evaluate the antibody response using a model and an assay measuring the desired function.
机译:在寻找针对HIV-1的有效疫苗中,期望期望中和抗体和具有效应子功能的非中和抗体的诱导,例如,抗体依赖性细胞细胞毒性(ADCC)。在追求能够诱导有效抗体反应的新型免疫原中,使用不同的主要促进策略用选定的抗原免疫兔子。我们从临床HIV-1亚型A和B的Env抗原免疫35种不同的兔子,包括单独使用DNA,单独使用蛋白质,蛋白质促进的DNA素。使用基于诱导氧毒素的测定与人外周血单核细胞作为效应细胞和CEM.NKR_(CCR5)细胞作为靶细胞,将兔血清筛选为ADCC活性。具有最高ADCC活性的基团进一步表征了HIV-1亚型之间的交叉反应性。诱导最有效和最广泛的ADCC反应的免疫原是三聚体GP140。与对应于免疫原的HIV-1亚型,ADCC活性最高。 ADCC活性不一定反映在假霉病毒-TZMBL测定中的中和活性,但两种抗病毒活动之间存在总体相关性。我们提出了一种兔疫苗接种模型和适用于筛选HIV-1疫苗候选的测定除了中和抗体之外还用于诱导ADCC介质抗体。能够诱导具有ADCC活性抗体的抗原和/或免疫策略不一定诱导中和活性,反之亦然。尽管如此,我们确定能够同时诱导两种类型反应的疫苗候选者,并且具有在不同亚型之间的交叉反应的ADCC活性。在搜索有效的疫苗候选方案时,重要的是使用模型和测量所需功能的测定来评估抗体响应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号